THE POTENTIAL ROLE OF L-CARNITINE SUPPLEMENTATION IN MANAGEMENT OF POLYENDOCRINE METABOLIC OVARIAN SYNDROME
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6262Keywords:
PMOS, PCOS, L-Carnitine, Nutrition, Oxidative Stress, Insulin ResistanceAbstract
Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly known as polycystic ovary syndrome, is a common endocrine and metabolic disorder affecting women of reproductive age, characterized by hyperandrogenism, ovulatory dysfunction, and insulin resistance. Despite its high prevalence, its pathophysiology remains incompletely understood, and current therapies are largely symptomatic. Increasing evidence implicates mitochondrial dysfunction, oxidative stress, and chronic low-grade inflammation in disease development. In this context, L-carnitine, a key regulator of mitochondrial fatty acid transport and energy metabolism, has emerged as a potential adjunctive therapeutic agent.
This narrative review summarizes current evidence on the role of L-carnitine and its derivatives in PMOS, integrating findings from randomized controlled trials, observational studies, systematic reviews, and preclinical models. Available data suggest that L-carnitine supplementation may improve metabolic parameters, including insulin resistance and lipid profiles, while exerting antioxidant and anti-inflammatory effects in ovarian tissue. However, evidence regarding endocrine and fertility outcomes remains inconsistent.
Although preclinical studies strongly support biological plausibility, clinical evidence is limited by heterogeneity in study design, small sample sizes, and reliance on surrogate endpoints. L-carnitine should therefore be considered a promising adjunct rather than a standard treatment for PMOS. Further large-scale randomized controlled trials are required to define optimal dosing, formulation, and patient subgroups most likely to benefit.
References
Abu-Zaid, A., Alghamdi, G. A., Alharbi, A. S., Baradwan, S., Saleh, S. A. K., Adly, H. M., Alzayed, M. M., Abuzaid, M., Sindi, R., Alsabban, M., & Alomar, O. (2025). Effect of L-carnitine supplementation on fertility outcomes among patients with polycystic ovary syndrome: A systematic review and dose-response meta-analysis of randomized clinical trials. Obstetrics and Gynecology Science, 68(4), 260–272. https://doi.org/10.5468/ogs.24272
Alesi, S., Ee, C., Moran, L. J., Rao, V., & Mousa, A. (2022). Nutritional supplements and complementary therapies in polycystic ovary syndrome. Advances in Nutrition, 13, 1243–1266. https://doi.org/10.1093/advances/nmab141
Alhasaniah, A. H. (2023). L-carnitine: Nutrition, pathology, and health benefits. Saudi Journal of Biological Sciences, 30(2), 103555. https://doi.org/10.1016/j.sjbs.2022.103555
Almannai, M., Alfadhel, M., & El-Hattab, A. W. (2019). Carnitine inborn errors of metabolism. Molecules, 24(18), 3251. https://doi.org/10.3390/molecules24183251
Baracat, E. C., Baracat, M. C. P., & Soares, J. M. (2022). Are there new insights for the definition of PCOS? Gynecological Endocrinology, 38(9), 703–704. https://doi.org/10.1080/09513590.2022.2121387
Bashir, S., Shah, I. M., Javeed, S., Rafiquee, A., Mir, B., Hassan Mir, R., Geer, M. I., & Ganie, M. A. (2026). Beyond conventional therapy: A comprehensive review of herbal, traditional, and emerging interventions for polycystic ovary syndrome. Current Molecular Medicine, 26. https://doi.org/10.2174/0115665240406897251206074722
Celik, F., Kose, M., Yilmazer, M., Köken, G. N., Arioz, D. T., & Kanat Pektas, M. (2017). Plasma L-carnitine levels of obese and non-obese polycystic ovary syndrome patients. Journal of Obstetrics and Gynaecology, 37(4), 476–479. https://doi.org/10.1080/01443615.2016.1264375
De Rubeis, M., Mascitti, I. A., Cocciolone, D., Placidi, M., Vergara, T., Di Emidio, G., Macchiarelli, G., Tatone, C., Nottola, S. A., & Palmerini, M. G. (2024). Morphological and redox/glycative alterations in the PCOS oviducts: Modulating effects of carnitines in PCOS mice. Biology, 13, 964. https://doi.org/10.3390/biology13120964
Di Emidio, G., Rea, F., Placidi, M., Rossi, G., Cocciolone, D., Virmani, A., Macchiarelli, G., Palmerini, M. G., D’alessandro, A. M., Artini, P. G., & Tatone, C. (2020). Regulatory functions of L-carnitine, acetyl, and propionyl L-carnitine in a PCOS mouse model: Focus on antioxidant/antiglycative molecular pathways in the ovarian microenvironment. Antioxidants, 9(9), 867–17. https://doi.org/10.3390/antiox9090867
El Sharkwy, I. A., & Abd El Aziz, W. M. (2019). Randomized controlled trial of N-acetylcysteine versus L-carnitine among women with clomiphene-citrate-resistant polycystic ovary syndrome. International Journal of Gynecology and Obstetrics, 147(1), 59–64. https://doi.org/10.1002/ijgo.12902
El Sharkwy, I. A., & Sharaf El-Din, M. (2019). L-carnitine plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effects: A randomized clinical trial. Gynecological Endocrinology, 35(8), 701–705. https://doi.org/10.1080/09513590.2019.1576622
Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment. Nature Reviews Endocrinology, 14(5), 270–284. https://doi.org/10.1038/nrendo.2018.24
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Human Reproduction, 19(1), 41–47. https://doi.org/10.1093/humrep/deh098
Fenkci, S. M., Fenkci, V., Oztekin, O., Rota, S., & Karagenc, N. (2008). Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Human Reproduction, 23(7), 1602–1606. https://doi.org/10.1093/humrep/den109
Genazzani, A. D., Battipaglia, C., Foschi, M., Semprini, E., Aio, C., Spelta, E., Kostrzak, A., Rusce, M. L., Szeliga, A., & Meczekalski, B. (2025). Improved insulin sensitivity and reproductive profile in overweight/obese PCOS patients undergoing integrative treatment with carnitines, L-arginine, L-cysteine and myo-inositol. Gynecological Endocrinology, 41(1), 2458710. https://doi.org/10.1080/09513590.2025.2458710
Genazzani, A. D., Prati, A., Genazzani, A. R., Battipaglia, C., Simoncini, T., Szeliga, A., Podfigurna, A., & Meczekalski, B. (2020). Synergistic effects of the integrative administration of acetyl-L-carnitine, L-carnitine, L-arginine and N-acetyl-cysteine on metabolic dynamics and on hepatic insulin extraction in overweight/obese patients with PCOS. Gynecological and Reproductive Endocrinology and Metabolism, 1(1), 56–63.
Gong, Y., Jiang, T., He, H., Wang, Y., Wu, G. L., Shi, Y., Cai, Q., Xiong, C. L., Shen, R., & Li, J. (2023). Effects of carnitine on glucose and lipid metabolic profiles and fertility outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis. Clinical Endocrinology, 98(5), 682–691. https://doi.org/10.1111/cen.14885
Hafezi, M., Arabipoor, A., Ghaffari, F., Vesali, S., Zareei, M., & Hessari, Z. H. (2024). Adding L-carnitine to antagonist ovarian stimulation doesn’t improve the outcomes of IVF/ ICSI cycle in patients with polycystic ovarian syndrome: A double-blind randomized clinical trial. Journal of Ovarian Research, 17(9), 1–9. https://doi.org/10.1186/s13048-023-01319-7
Harmeyer, J. (2002). The physiological role of L-carnitine. Lohmann Information, 27, 1–8.
Hu, X., Wang, W., Su, X., Peng, H., Tan, Z., Li, Y., & Huang, Y. (2023). Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: A systematic review and network meta-analysis. PeerJ, 11, e16410. https://doi.org/10.7717/peerj.16410
Ismail, A. M., Hamed, A. H., Saso, S., & Thabet, H. H. (2014). Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial. European Journal of Obstetrics and Gynecology and Reproductive Biology, 180(1), 148–152. https://doi.org/10.1016/j.ejogrb.2014.06.008
Jamilian, M., Foroozanfard, F., Kavossian, E., Aghadavod, E., Amirani, E., Mahdavinia, M., Mafi, A., & Asemi, Z. (2019). Carnitine and chromium co-supplementation affects mental health, hormonal, inflammatory, genetic, and oxidative stress parameters in women with polycystic ovary syndrome. Journal of Psychosomatic Obstetrics and Gynecology, 1–9. https://doi.org/10.1080/0167482X.2018.1557144
Jamilian, M., Foroozanfard, F., Kavossian, E., Kia, M., Aghadavod, E., Amirani, E., & Asemi, Z. (2019). Effects of chromium and carnitine co-supplementation on body weight and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Biological Trace Element Research, 193, 334–341. https://doi.org/10.1007/s12011-019-01720-8
Kalhori, Z., Mehranjani, M. S., Azadbakht, M., & Shariatzadeh, M. A. (2019). L -carnitine improves endocrine function and folliculogenesis by reducing inflammation, oxidative stress and apoptosis in mice following induction of polycystic ovary syndrome. Reproduction, Fertility and Development, 31, 282–293. https://doi.org/10.1071/RD18131
Liao, D., Liu, X., Yuan, X., Feng, P., Ouyang, Z., Liu, Y., & Li, C. (2022). Clinical evidence of the effects of carnitine supplementation on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A systematic review and meta-analysis. Gynecological Endocrinology, 38(2), 110–115. https://doi.org/10.1080/09513590.2021.1988559
Maleki, V., Jafari-Vayghan, H., Kashani, A., Moradi, F., Vajdi, M., Kheirouri, S., & Alizadeh, M. (2019). Potential roles of carnitine in patients with polycystic ovary syndrome: A systematic review. Gynecological Endocrinology, 35(6), 463–469. https://doi.org/10.1080/09513590.2019.1576616
Mazza, T., Scalise, M., Console, L., Galluccio, M., Giangregorio, N., Tonazzi, A., Pochini, L., & Indiveri, C. (2024). Carnitine traffic and human fertility. Biochemical Pharmacology, 230, 116565. https://doi.org/10.1016/J.BCP.2024.116565
Palmerini, M. G., Macchiarelli, G., Cocciolone, D., Mascitti, I. A., Placidi, M., Vergara, T., Di Emidio, G., & Tatone, C. (2023). Modulating morphological and redox/glycative alterations in the PCOS uterus: Effects of carnitines in PCOS mice. Biomedicines, 11, 374. https://doi.org/10.3390/biomedicines11020374
Pandey, C., Maunder, A., Liu, J., Vaddiparthi, V., Costello, M. F., Bahri-Khomami, M., Mousa, A., & Ee, C. (2025). The role of nutrient supplements in female infertility: An umbrella review and hierarchical evidence synthesis. Nutrients , 17(1), 57. https://doi.org/10.3390/nu17010057
Pękala, J., Patkowska-Sokoła, B., Bodkowski, R., Jamroz, D., Nowakowski, P., Lochyński, S., & Librowski, T. (2011). L-carnitine-metabolic functions and meaning in humans life. Current Drug Metabolism, 12, 667–678.
Petrillo, T., Battipaglia, C., Virmani, M. A., Genazzani, A. R., & Genazzani, A. D. (2021). Neuroendocrine effects of carnitines on reproductive impairments. International Journal of Molecular Sciences, 22, 10781. https://doi.org/10.3390/ijms221910781
Petrillo, T., Semprini, E., Tomatis, V., Arnesano, M., Ambrosetti, F., Battipaglia, C., Sponzilli, A., Ricciardiello, F., Genazzani, A. R., & Genazzani, A. D. (2022). Putative complementary compounds to counteract insulin-resistance in PCOS patients. Biomedicines, 10, 1924. https://doi.org/10.3390/biomedicines10081924
Placidi, M., Di Emidio, G., Virmani, A., D’Alfonso, A., Artini, P. G., D’alessandro, A. M., & Tatone, C. (2022). Carnitines as mitochondrial modulators of oocyte and embryo bioenergetics. Antioxidants, 11, 745. https://doi.org/10.3390/antiox11040745
Placidi, M., Vergara, T., Casoli, G., Flati, I., Capece, D., Artini, P. G., Virmani, A., Zanatta, S., D’Alessandro, A. M., Tatone, C., & Di Emidio, G. (2023). Acyl-carnitines exert positive effects on mitochondrial activity under oxidative stress in mouse oocytes: A potential mechanism underlying carnitine efficacy on PCOS. Biomedicines, 11, 2474. https://doi.org/10.3390/biomedicines11092474
Salehpour, S., Nazari, L., Hoseini, S., Moghaddam, P. B., & Gachkar, L. (2019). Effects of L-carnitine on polycystic ovary syndrome. Jornal Brasileiro de Reproducao Assistida, 23(4), 392–395. https://doi.org/10.5935/1518-0557.20190033
Sangouni, A. A., Pakravanfar, F., Ghadiri-Anari, A., Nadjarzadeh, A., Fallahzadeh, H., & Hosseinzadeh, M. (2022). The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: A randomized clinical trial. European Journal of Nutrition, 61, 1199–1207. https://doi.org/10.1007/s00394-021-02659-0
Sangouni, A. A., Sasanfar, B., Ghadiri-Anari, A., & Hosseinzadeh, M. (2021). Effect of L-carnitine supplementation on liver fat content and cardiometabolic indices in overweight/obese women with polycystic ovary syndrome: A randomized controlled trial. Clinical Nutrition ESPEN, 46, 54–59. https://doi.org/10.1016/j.clnesp.2021.08.005
Seline, K.-G., & Johein, H. (2007). The determination of L-carnitine in several food samples. Food Chemistry, 105, 793–804. https://doi.org/10.1016/j.foodchem.2007.01.058
Sheida, A., Davar, R., Tabibnejad, N., & Eftekhar, M. (2021). The effect of adding L-carnitine to the GnRH-antagonist protocol on assisted reproductive technology outcome in women with polycystic ovarian syndrome: A randomized clinical trial. Gynecological Endocrinology, 39(1). https://doi.org/10.1080/09513590.2021.1878135
Shukri, M. F. M., Norhayati, M. N., Badrin, S., & Kadir, A. A. (2022). Effects of L-carnitine supplementation for women with polycystic ovary syndrome: A systematic review and meta-analysis. PeerJ, 10, e13992. https://doi.org/10.7717/peerj.13992
Stein, I. F., & Leventhal, M. L. (1935). Amenorrhea associated with bilateral polycystic ovaries. American Journal of Obstetrics and Gynecology, 29, 181–191. https://doi.org/10.1016/s0002-9378(15)30642-6
Talari, H. R., Azad, Z. J., Hamidian, Y., Samimi, M., Gilasi, H. R., Afshar, F. E., Ostadmohammadi, V., & Asemi, Z. (2019). Effects of carnitine administration on carotid intima-media thickness and inflammatory factors in patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. International Journal of Preventive Medicine, 10(89), 1–6. https://doi.org/10.4103/ijpvm.IJPVM_2_18
Tauqir, S., Israr, M., Rauf, B., Malik, M. O., Habib, S. H., Shah, F. A., Usman, M., Raza, M. A., Shah, I., Badshah, H., Ehtesham, E., & Shah, M. (2021). Acetyl-L-carnitine ameliorates metabolic and endocrine alterations in women with PCOS: A double-blind randomized clinical trial. Advances in Therapy, 38(7), 3842–3856. https://doi.org/10.1007/s12325-021-01789-5
Teede, H. J., Khomami, M. B., Morman, R., Laven, J. S. E., Joham, A. E., Costello, M. F., Patil, M., Rees, D. A., Berry, L., Cree, M. G., Zhao, H., Norman, R. J., Dokras, A., Piltonen, T., & Global Name Change Consortium. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: A multistep global consensus process. Lancet (London, England), 407, 2329–2339. https://doi.org/10.1016/S0140-6736(26)00717-8
Vigerust, N. F., Bohov, P., Bjorndal, B., Seifert, R., Nygård, O., Svardal, A., Glintborg, D., Berge, R. K., & Gaster, M. (2012). Free carnitine and acylcarnitines in obese patients with polycystic ovary syndrome and effects of pioglitazone treatment. Fertility and Sterility, 98(6), 1620–1626. https://doi.org/10.1016/j.fertnstert.2012.08.024
Wang, D.-D., Li, Y.-F., Mao, Y.-Z., He, S.-M., Zhu, P., & Wei, Q.-L. (2022). A machine-learning approach for predicting the effect of carnitine supplementation on body weight in patients with polycystic ovary syndrome. Frontiers in Nutrition, 9, 1–8. https://doi.org/10.3389/fnut.2022.851275
Zhang, Y., Ma, H., Sun, P., Liu, K., Wang, J., & Zhao, W. (2025). Therapeutic targets of L-carnitine against polycystic ovary syndrome and the underlying signaling mechanisms. Medicine (United States), 104(51), 1–10. https://doi.org/10.1097/MD.0000000000046532
Zhao, G., Fan, Y., Li, R., Huang, Y., Li, W., Zhao, Y., Zhou, M., & He, J. (2025). The effectiveness of nutritional supplements in improving polycystic ovary syndrome in women: A systematic review and network meta-analysis. Reproductive Biology and Endocrinology, 23, 1–20. https://doi.org/10.1186/s12958-025-01409-9
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Melania Czapla, Karolina Kubala, Julia Tesyna, Aleksandra Obszańska, Jakub Tomczyszyn, Kamil Marchlik
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
